Are PCSK9 meds worth the cost? Only if Amgen, Sanofi and Regeneron slash prices by two-thirds: JAMA - FiercePharma

Bidness ETCAre PCSK9 meds worth the cost? Only if Amgen, Sanofi and Regeneron slash prices by two-thirds: JAMAFiercePharmaBut this study comes from the Journal of the American Medical Association, rather than a controversial U.S. analytics firm or a famously cost-conscious set of gatekeepers in England. It's authored by academic researchers rather than payers with an ...Price of new cholesterol drugs challenge health care systemDaily RecordCost-effectiveness of PCSK9 inhibitors for heterozygous FH or ASCVDPharmacy Today, American Pharmacists Association, pharmacist.comPCSK9 inhibitors are not cost-effective, concludes JAMA articleThe Pharma Letter (registration)Bidness ETC -Doctors Loungeall 14 news articles »